Abstract
The nasal administration of insulin preparation to rats resulted in dose-dependent hypoglycemia. The absorption of insulin through the nasal mucosa was enhanced when a surfactant, among various non-ionic, anionic and amphoteric surfactants, including the bile acid salts, saponin and peptidelipid (surfactin), was added to the insulin solution. Among the non-ionic surfactants, the addition of an ether type having a HLB(hydrophile-lipophile balance) value from 8 to 14 was found to produce the highest promoting effect on the nasal absorption of insulin. The bioavailability of nasally administered insulin with the surfactant was estimated to be about 30% by comparing the hypoglycemic effect with that obtained after intravenous administration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
